AIM IMMUNOTECH INC. Debt Conversion, Original Debt, Amount
AIM IMMUNOTECH INC. (AIM) reported Debt Conversion, Original Debt, Amount of $134.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2025-08-14
- AIM IMMUNOTECH INC. debt conversion, original debt, amount for the quarter ending 2025-06-30 was $66.00K.
- AIM IMMUNOTECH INC. debt conversion, original debt, amount for the quarter ending 2025-03-31 was $68.00K.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month |
|---|---|---|
| 2025-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $134.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $68.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |